Is there any demo copy available for Newbler?
Unconfigured Ad
Collapse
X
-
MIRA should be nice alternative as well. I would go on wgs or MIRA ... or check velvet... in my mind these three are the most promising. I tested a bit CLC Genome Workbench and was not particularly impressed...
Originally posted by strob View PostIf you use 454 data you can just ask for the Newbler software. We did it this way and we received a DVD containing everything we need.
Comment
-
-
Not so here in Chile...
I did that and I was told I can get the software only if I have a GS FLX system. I get this answer from a representant of Roche here in Chile.Originally posted by strob View PostIf you use 454 data you can just ask for the Newbler software. We did it this way and we received a DVD containing everything we need.
---sram
Comment
-
-
I really have no idea why Roche insist that only people with the sequencer are allowed the software... They are actively damaging their software's status among the bioinformatics community.
Seriously, what do they expect? Only sequencing centres will do bioinf analysis with 454 data? Clearly not. Therefore we are forced by Roche NOT to use Roche products... What kind of crazy logic is that?
Dear Roche,
Please make Newbler open source immediately.
Sincerely,
Someone who imagines that you actually care about improving your software and increasing its user base.
sram, try writing to the people who gave you the data, and ask them to ask Roach on your behalf.
Comment
-
-
Dan, thank you. I will do that. I am receiving the data from research centres in Europe who work with us in some projects. In fact some samples are ours and they are supporting us with the sequencing. Perhaps Roche have a different policy in Europe.. taking in account the message from strob, who appear to be writing from Belgium.Originally posted by dan View PostI really have no idea why Roche insist that only people with the sequencer are allowed the software... They are actively damaging their software's status among the bioinformatics community.
Seriously, what do they expect? Only sequencing centres will do bioinf analysis with 454 data? Clearly not. Therefore we are forced by Roche NOT to use Roche products... What kind of crazy logic is that?
Dear Roche,
Please make Newbler open source immediately.
Sincerely,
Someone who imagines that you actually care about improving your software and increasing its user base.
sram, try writing to the people who gave you the data, and ask them to ask Roach on your behalf.
I totally agree with you about Roche should make this software available for academic research. For commercial uses is another thing.
---sram
Comment
-
Latest Articles
Collapse
-
by SEQadmin2
Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.
The systematic characterization of the human proteome has...-
Channel: Articles
07-20-2026, 11:48 AM -
-
by SEQadmin2
Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
...-
Channel: Articles
07-09-2026, 11:10 AM -
-
by SEQadmin2
Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.
There is no single reason why many patients don’t respond to treatment as expected. Cancer is...-
Channel: Articles
07-08-2026, 05:17 AM -
ad_right_rmr
Collapse
News
Collapse
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Started by SEQadmin2, 07-24-2026, 12:17 PM
|
0 responses
19 views
0 reactions
|
Last Post
by SEQadmin2
07-24-2026, 12:17 PM
|
||
|
Started by SEQadmin2, 07-23-2026, 11:41 AM
|
0 responses
19 views
0 reactions
|
Last Post
by SEQadmin2
07-23-2026, 11:41 AM
|
||
|
Started by SEQadmin2, 07-20-2026, 11:10 AM
|
0 responses
25 views
0 reactions
|
Last Post
by SEQadmin2
07-20-2026, 11:10 AM
|
||
|
Started by SEQadmin2, 07-13-2026, 10:26 AM
|
0 responses
38 views
0 reactions
|
Last Post
by SEQadmin2
07-13-2026, 10:26 AM
|
Comment